Favorites Sign in

One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
  1. Home
  2. Companies
  3. Abiomed
  4. Financial Statements
Abiomed logo
Abiomed ABMD
report update icon

Quarterly report 2023-Q2
added 05-23-2026

Abiomed Financial Statements 2022-2009 | ABMD

Annual Financial Statements Abiomed

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Market Cap

 		- 16.2 M 14.6 M 7.66 B 14.4 B 8.1 B 4.76 B 3.67 B 1.5 B 1.05 B 516 M 686 M - -

Shares

 		45.4 K 45.1 K 45.2 K 44.9 M 44.2 M 43.2 M 42.2 M 40.6 M 39.3 M 39.1 M 38.4 M 37.2 M 36.9 M -

Historical Prices

 		- 359 324 171 325 187 113 90.3 38.1 26.7 13.4 18.5 - -

Net Income

 		137 M 226 M 203 M 69.2 M 44.9 M 13.4 M 15.4 M 10.6 M 12.7 M 4.39 M 2.68 M 2.92 M -19 M -

Revenue

 		1.03 B 848 M 841 M 222 M 174 M 154 M 115 M 85.8 M 62 M 46.2 M 38.2 M 32.2 M 85.7 M -

Cost of Revenue

 		188 M 162 M 151 M 40 M 30.1 M 25 M 19 M - - - - - - -

Gross Profit

 		- - 690 M 640 M 495 M 375 M 279 M 190 M 146 M 127 M 102 M 79.2 M - -

Operating Income

 		141 M 230 M 249 M 225 M 157 M 90.1 M 65.1 M 28.7 M 8.36 M 16.5 M 1.52 M -11.2 M -25.1 M -

Interest Expense

 		49.8 M 58.7 M 7.61 M 30.4 M -388 K -349 K 339 K -97 K 49 K 326 K 9 K -143 K -39 K -

EBITDA

 		169 M 254 M 270 M 239 M 168 M 96.3 M 68.4 M 31.4 M 10.9 M 19.3 M 5.86 M -7.24 M -20.2 M -

Operating Expenses

 		- 132 M 119 M 111 M 104 M 84.3 M 70.3 M 55.6 M 38.5 M 32.1 M 27.2 M 23.7 M - -

General and Administrative Expenses

 		423 M 334 M 342 M 322 M 263 M 218 M 164 M 126 M 107 M 84.2 M 71.7 M 62.3 M 60.8 M -

All numbers in USD currency

Quarterly Income Statement Abiomed

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 		45.4 M 45.6 M - 45.5 M 45.4 M 45.3 M 45.5 M 45.2 M 45.1 M 45 M 45.2 M 45.1 M 45.3 M 45.2 M 45.1 M 45 M 45 M 44.5 M 45 M 44.2 M 44.1 M 43.9 M 44.2 M 43.4 M 43.1 M 42.8 M 43.4 M 42.4 M 42.2 M 42.6 M 42.4 M 42.1 M 42 M 41.7 M 40.9 M 40.9 M 40.4 M 40.1 M 39.6 M 39.6 M 39.3 M 38.7 M 39.4 M 39.4 M 39.4 M 39.1 M 38.5 M 38.5 M 38.3 M 38.5 M

Net Income

 		106 M 54.6 M - 45.8 M 57 M -26.5 M 45.8 M 61.9 M 62.2 M 44.6 M 61.9 M 69.2 M 13.1 M 88.9 M 69.2 M 44.9 M 50.1 M 90.1 M 44.9 M 13.4 M 24.5 M 37.4 M 13.4 M 15.4 M 8.88 M 12.9 M 15.4 M 10.6 M 7.74 M 12.9 M 10.6 M 10.6 M 7.74 M 8.86 M 12.7 M 12.7 M 3.84 M -1.71 M 4.39 M 4.39 M 1.06 M -1.72 M 2.68 M 2.68 M 5.47 M 3.12 M 2.92 M 2.92 M 601 K -4.59 M

Revenue

 		266 M 277 M - 261 M 248 M 253 M 261 M 232 M 210 M 165 M 232 M 222 M 205 M 208 M 222 M 201 M 182 M 180 M 201 M 154 M 133 M 132 M 154 M 115 M 103 M 103 M 115 M 85.8 M 76.4 M 103 M 85.8 M 85.8 M 76.4 M 73.4 M 62 M 62 M 51.9 M 48.8 M 46.2 M 46.2 M 44.3 M 42.7 M 38.2 M 38.2 M 37.4 M 38.8 M 32.2 M 32.2 M 29.5 M 27.4 M

Cost of Revenue

 		48.9 M 52.6 M - 47.6 M 43.9 M 45.2 M 47.6 M 41.1 M 38.7 M 36 M 41.1 M 40 M 34.9 M 37.1 M 40 M 34 M 29.8 M 30.8 M 34 M 34 M 29.8 M 30.1 M 25 M 21.6 M 21.9 M 19.3 M 19 M 17.3 M 15.1 M - - - - - - - - - - - - - - - - - - - - -

Operating Income

 		58 M 66 M - 64.6 M 60.4 M -49.3 M 64.6 M 71.4 M 61.3 M 34.1 M 71.4 M 70.3 M 60.2 M 60.7 M 70.3 M 62.4 M 50.3 M 46.7 M 62.4 M 44.8 M 31.7 M 33.1 M 44.8 M 25.4 M 14.5 M 21.2 M 25.4 M 17.4 M 12.8 M - 17.4 M 45.3 M 27.8 M 15 M 13.7 M 13.7 M 4.18 M -1.54 M 4.59 M 4.59 M 1.4 M -1.31 M 2.92 M 2.92 M 5.93 M 3.56 M 2.23 M 2.23 M 766 K -4.42 M

Interest Expense

 		80.7 M 3.77 M - -7.58 M 5.86 M 38.9 M -7.58 M 7.94 M 9.76 M 24.6 M 7.94 M 23.7 M -45.8 M 39.4 M 23.7 M -20 K -158 K 188 K -20 K -81 K -23 K 79 K -81 K -34 K -114 K -77 K -34 K -29 K 87 K - -29 K 111 K 140 K 53 K -10 K -10 K -39 K 11 K 20 K 20 K 6 K -21 K 324 K 324 K -9 K -4 K 39 K 39 K 66 K -81 K

EBITDA

 		71.3 M 72.7 M - 85.4 M 74.3 M -42.4 M 64.6 M 88.6 M 72.5 M 39.5 M 71.4 M 84.7 M 69.2 M 65.1 M 70.3 M 72.3 M 56.7 M 49.7 M 62.4 M 52.9 M 37 M 35.5 M 44.8 M 29.9 M 17.5 M 22.6 M 25.4 M 19.7 M 14.2 M - 17.4 M 47.5 M 28.5 M 15.7 M 13.7 M 15.5 M 5.37 M -917 K 4.59 M 6.46 M 2.72 M -655 K 2.92 M 5 M 7.38 M 4.4 M 2.6 M 5.32 M 2.89 M -3.38 M

Operating Expenses

 		- - - - - - - - - 132 M 119 M 110 M 94.8 M 109 M 111 M 110 M 110 M 107 M 104 M 102 M 102 M 96.8 M 84.3 M 79.5 M 77.5 M 76.4 M 70.3 M 71.1 M 66.7 M 59.5 M 55.6 M 51.4 M 47.5 M 44.4 M 38.5 M 38.1 M 40.7 M 36.6 M 32.1 M 33.9 M 35.3 M 30.7 M 27.2 M 24.3 M 27.8 M 27.6 M 23.7 M 23.2 M 25.9 M -

General and Administrative Expenses

 		117 M 118 M - 108 M 103 M 103 M 108 M 86.2 M 79.2 M 68.4 M 86.2 M 85.7 M 86 M 86.1 M 85.7 M 80.2 M 78.9 M 81.1 M 80.2 M 66.6 M 60.1 M 60.6 M 66.6 M 53.9 M 53.1 M 51 M 53.9 M 41.9 M 39.8 M - 41.9 M 119 M 77.2 M 37.3 M 30.1 M 30.1 M 29.5 M 31.6 M 24.4 M 24.4 M 26.2 M 28 M 20.9 M 20.9 M 18.4 M 21 M 17.2 M 17.2 M 16.3 M 18.2 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Abiomed ABMD
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Abiomed plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Avanos Medical Avanos Medical
AVNS
 		$ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
 		- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
 		- 37.08 % $ 85.7 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
 		$ 1.83 -4.69 % $ 40.3 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
 		- 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
 		- -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
 		- - $ 140 M usaUSA
GBS GBS
GBS
 		- -0.57 % $ 7.12 M usaUSA
NanoVibronix NanoVibronix
NAOV
 		- - $ 1.08 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
 		- 10.0 % $ 610 K usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
 		- 7.07 % $ 66.1 M israelIsrael
STRATA Skin Sciences STRATA Skin Sciences
SSKN
 		- - $ 6.6 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
 		$ 110.59 0.07 % $ 193 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
 		- - $ 162 M franceFrance
Align Technology Align Technology
ALGN
 		$ 174.54 0.16 % $ 12.7 B usaUSA
TELA Bio TELA Bio
TELA
 		$ 0.83 -4.37 % $ 39 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
 		$ 104.0 -0.68 % $ 60.8 B usaUSA
Avinger Avinger
AVGR
 		- -20.74 % $ 369 K usaUSA
CONMED Corporation CONMED Corporation
CNMD
 		$ 51.21 -1.42 % $ 1.59 B usaUSA
Medtronic PLC Medtronic PLC
MDT
 		$ 101.59 -1.17 % $ 130 B usaUSA
MiMedx Group MiMedx Group
MDXG
 		$ 3.37 1.36 % $ 498 M usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
 		- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
 		- 3.55 % $ 7.96 M usaUSA
Myomo Myomo
MYO
 		$ 1.32 -5.71 % $ 55.2 M usaUSA
Insulet Corporation Insulet Corporation
PODD
 		$ 148.03 -1.19 % $ 10.4 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
 		$ 7.66 4.36 % $ 232 M canadaCanada
Quanterix Corporation Quanterix Corporation
QTRX
 		$ 3.3 -2.51 % $ 141 M usaUSA
Viveve Medical Viveve Medical
VIVE
 		- -15.35 % $ 1.71 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
 		$ 30.96 -0.29 % $ 26.8 B britainBritain
Sensus Healthcare Sensus Healthcare
SRTS
 		$ 3.42 7.39 % $ 55.8 M usaUSA
Stryker Corporation Stryker Corporation
SYK
 		$ 324.18 -0.48 % $ 124 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
 		$ 26.61 0.08 % $ 609 M usaUSA
TransMedics Group TransMedics Group
TMDX
 		$ 91.02 -2.95 % $ 3.09 B usaUSA
SmileDirectClub SmileDirectClub
SDC
 		- -53.45 % $ 9.71 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
 		$ 9.04 1.01 % $ 352 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
 		$ 18.45 0.03 % $ 764 M usaUSA
Acutus Medical Acutus Medical
AFIB
 		- -26.83 % $ 2.62 M usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
 		$ 0.09 -8.14 % $ 925 K usaUSA
BIOLASE BIOLASE
BIOL
 		- -13.19 % $ 166 K usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
 		- 0.28 % $ 270 M usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
 		$ 0.28 -0.68 % $ 39.1 M usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
 		$ 107.39 -0.87 % $ 21.3 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
 		- - $ 475 M usaUSA
NuVasive NuVasive
NUVA
 		- - $ 2.07 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
 		$ 0.37 59.63 % $ 24 M israelIsrael
Penumbra Penumbra
PEN
 		$ 321.48 -0.11 % $ 12.5 B usaUSA
Conformis Conformis
CFMS
 		- - $ 16.4 M usaUSA
ViewRay ViewRay
VRAY
 		- 1.54 % $ 468 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
 		- 10.28 % $ 55.5 M israelIsrael
Boston Scientific Corporation Boston Scientific Corporation
BSX
 		$ 44.68 1.49 % $ 66.1 B usaUSA